Adagene Soars 15% After a $2.5B Multi-Target Collaboration With Sanofi
(Adagene) Shares of Adagene Inc. rose more than 15% on Wednesday after a license agreement with Sanofi that will see the company earn up to $2.5 billion, plus royalties. The…
Adagene